Omnicare Reaches New 52-Week High (OCR)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Omnicare (NYSE: OCR) hit a new 52-week high Friday as it is currently trading at $39.34, above its previous 52-week high of $39.23 with 531,991 shares traded as of 12:20 p.m. ET. Average volume has been one million shares over the past 30 days.

Omnicare has a market cap of $4.29 billion and is part of the services sector and wholesale industry. Shares are up 7.6% year to date as of the close of trading on Thursday.

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. The company has a P/E ratio of 21.7, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Omnicare as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Omnicare Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

null

More from Markets

Daimler Slumps to 5-Year Low After Profit Warning Following Surprise Q3 Earnings

Daimler Slumps to 5-Year Low After Profit Warning Following Surprise Q3 Earnings

Dow Rebounds From Thursday's Sharp Decline, P&G Jumps

Dow Rebounds From Thursday's Sharp Decline, P&G Jumps

PayPal Surges as Results, New Partnerships Boost Outlook

PayPal Surges as Results, New Partnerships Boost Outlook

American Express Beats on Earnings, Stock Rises

American Express Beats on Earnings, Stock Rises

The Fed Pulls a Miley Cyrus and Comes In Like a Wrecking Ball

The Fed Pulls a Miley Cyrus and Comes In Like a Wrecking Ball